Blueprint Medicines Corp.*
|
| 9,021
| 877,112
|
Bolt Biotherapeutics, Inc.*
|
| 2,074
| 68,255
|
Brainstorm Cell Therapeutics, Inc.*
|
| 4,968
| 19,027
|
Bridgebio Pharma, Inc.* (a)
|
| 15,330
| 944,328
|
C4 Therapeutics, Inc.* (a)
|
| 1,789
| 66,175
|
Cabaletta Bio, Inc.*
|
| 2,237
| 24,831
|
Calithera Biosciences, Inc.*
|
| 11,637
| 28,162
|
Calyxt, Inc.*
|
| 1,724
| 10,378
|
CareDx, Inc.*
|
| 8,190
| 557,657
|
CASI Pharmaceuticals, Inc.*
|
| 11,558
| 27,739
|
Catabasis Pharmaceuticals, Inc.*
|
| 3,373
| 9,748
|
Catalyst Biosciences, Inc.*
|
| 5,003
| 25,215
|
Catalyst Pharmaceuticals, Inc.*
|
| 16,764
| 77,282
|
CEL-SCI Corp* (a)
|
| 5,921
| 90,058
|
Centogene NV*
|
| 1,413
| 17,140
|
Checkmate Pharmaceuticals, Inc.*
|
| 1,473
| 17,882
|
Checkpoint Therapeutics, Inc.*
|
| 8,015
| 25,167
|
ChemoCentryx, Inc.*
|
| 8,086
| 414,327
|
Chimerix, Inc.*
|
| 9,749
| 93,980
|
Chinook Therapeutics, Inc.*
|
| 2,328
| 36,177
|
Cidara Therapeutics, Inc.*
|
| 6,224
| 16,556
|
Clovis Oncology, Inc.* (a)
|
| 13,590
| 95,402
|
Codiak Biosciences, Inc.*
|
| 906
| 13,662
|
Cohbar, Inc.*
|
| 4,570
| 6,215
|
Coherus Biosciences, Inc.*
|
| 9,456
| 138,152
|
Concert Pharmaceuticals, Inc.*
|
| 5,028
| 25,090
|
Constellation Pharmaceuticals, Inc.*
|
| 4,889
| 114,354
|
Contrafect Corp.*
|
| 3,791
| 18,197
|
Corbus Pharmaceuticals Holdings, Inc.*
|
| 11,734
| 23,116
|
Cortexyme, Inc.* (a)
|
| 2,440
| 87,913
|
Crinetics Pharmaceuticals, Inc.*
|
| 4,617
| 70,548
|
Cue Biopharma, Inc.*
|
| 4,881
| 59,548
|
Cullinan Oncology, Inc*
|
| 2,147
| 89,466
|
Cyclerion Therapeutics, Inc.*
|
| 3,714
| 10,362
|
Cytokinetics, Inc.*
|
| 10,895
| 253,418
|
CytomX Therapeutics, Inc.*
|
| 10,055
| 77,725
|
Decibel Therapeutics, Inc.*
|
| 1,170
| 13,291
|
Deciphera Pharmaceuticals, Inc.*
|
| 6,294
| 282,223
|
Denali Therapeutics, Inc.*
|
| 10,250
| 585,275
|
DermTech, Inc.* (a)
|
| 1,673
| 84,972
|
Dicerna Pharmaceuticals, Inc.*
|
| 10,740
| 274,622
|
Dyadic International, Inc.*
|
| 3,320
| 18,227
|
Dynavax Technologies Corp.*
|
| 17,284
| 169,902
|
Dyne Therapeutics, Inc.*
|
| 2,371
| 36,822
|
Eagle Pharmaceuticals, Inc.*
|
| 1,677
| 69,998
|
Editas Medicine, Inc.* (a)
|
| 10,885
| 457,170
|
Eiger BioPharmaceuticals, Inc.*
|
| 5,072
| 44,887
|
Emergent BioSolutions, Inc.*
|
| 7,347
| 682,610
|
Enanta Pharmaceuticals, Inc.*
|
| 3,067
| 151,264
|
Enochian Biosciences, Inc.*
|
| 2,438
| 8,631
|
Epizyme, Inc.*
|
| 14,537
| 126,617
|
Esperion Therapeutics, Inc.* (a)
|
| 4,147
| 116,323
|
Evelo Biosciences, Inc.*
|
| 3,924
| 41,987
|
Exicure, Inc.*
|
| 9,901
| 21,584
|
Fate Therapeutics, Inc.*
|
| 12,409
| 1,023,122
|
Fennec Pharmaceuticals, Inc.*
|
| 3,717
| 23,083
|
FibroGen, Inc.*
|
| 13,719
| 476,187
|
Five Prime Therapeutics, Inc.*
|
| 5,241
| 197,428
|